Prognostic value of spleen tyrosine kinase in human solid tumors.

about

Prognostic value of spleen tyrosine kinase in human solid tumors.

Item

http://www.wikidata.org/entity/Q55345256

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Prognostic value of spleen tyrosine kinase in human solid tumors.

@en

Prognostic value of spleen tyrosine kinase in human solid tumors.

@nl

type

Item

label

Prognostic value of spleen tyrosine kinase in human solid tumors.

@en

Prognostic value of spleen tyrosine kinase in human solid tumors.

@nl

prefLabel

Prognostic value of spleen tyrosine kinase in human solid tumors.

@en

Prognostic value of spleen tyrosine kinase in human solid tumors.

@nl

P1476

Prognostic value of spleen tyrosine kinase in human solid tumors.

@en

P2093

Beibei Ni

http://www.w3.org/2001/XMLSchema#string

Shi Li

http://www.w3.org/2001/XMLSchema#string

Yang Liu

http://www.w3.org/2001/XMLSchema#string

Yuqian Huang

http://www.w3.org/2001/XMLSchema#string

Zesong Li

http://www.w3.org/2001/XMLSchema#string

P2860

The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells

Bias in meta-analysis detected by a simple, graphical test

Structural and biophysical characterization of the Syk activation switch

Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules.

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Operating characteristics of a rank correlation test for publication bias

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

Practical methods for incorporating summary time-to-event data into meta-analysis

Aggregate data meta-analysis with time-to-event outcomes.

Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer

P304

3377-3384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S163136

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29922076

http://www.w3.org/2001/XMLSchema#string

P932

5996858

http://www.w3.org/2001/XMLSchema#string